Log in

ASX:ALQALS Stock Price, Forecast & News

-0.11 (-1.70 %)
(As of 05/12/2020)
Today's Range
Now: A$6.37
50-Day Range
MA: A$6.37
52-Week Range
Now: A$6.37
Volume1.59 million shs
Average Volume2.06 million shs
Market Capitalization$3.07 billion
P/E Ratio24.22
Dividend Yield2.67%
ALS Limited provides analytical testing services in Australia, Canada, the United States, and internationally. The company's Life Sciences segment offers analytical testing and sampling, and remote monitoring services for the environmental, food, pharmaceutical, and consumer products markets. It provides analytical testing data to assist consulting and engineering firms, industries, and governments. The company's Industrial segment offers diagnostic testing and engineering solutions for the energy, resources, transportation, and infrastructure sectors. This segment serves asset owners, operators, constructors, and equipment manufacturers in the power, petrochemical, mining, minerals processing, water, infrastructure, and transportation industries. The company's Commodities segment provides testing services for the mining and mineral exploration companies in geochemistry, metallurgy, inspection, and coal quality areas. This segment's services cover the resource life-cycle, including exploration, feasibility, optimization, production, design, development, trade, and rehabilitation. It also provides coal sampling, analysis and certification, formation evaluation, and related analytical testing services; and field and laboratory services, such as bore core, testing, consulting, quality management, and superintendent services to the coal industry. The company was formerly known as Campbell Brothers Limited and changed its name to ALS Limited in August 2012. ALS Limited was founded in 1863 and is headquartered in Brisbane, Australia.
Read More
ALS logo

Beat the Market (BTM) Rank

Analyst Opinion: 0.0Community Rank: 2.1Dividend Strength: 1.7Insider Behavior: 3.0Valuation: 0.6 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

1.48 out of 5 stars

Industry, Sector and Symbol

Industry Business Services



Sales & Book Value

Annual Sales$1.83 billion
Cash FlowA$0.88 per share
Book ValueA$2.28 per share



Market Cap$3.07 billion
Next Earnings DateN/A
OptionableNot Optionable

Receive ALQ News and Ratings via Email

Sign-up to receive the latest news and ratings for ALQ and its competitors with MarketBeat's FREE daily newsletter.

ALS (ASX:ALQ) Frequently Asked Questions

How has ALS's stock been impacted by COVID-19 (Coronavirus)?

ALS's stock was trading at A$6.86 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization. Since then, ALQ shares have decreased by 7.1% and is now trading at A$6.37. View which stocks have been most impacted by Coronavirus.

How often does ALS pay dividends? What is the dividend yield for ALS?

ALS declared a Final dividend on Thursday, May 28th. Shareholders of record on Monday, July 6th will be paid a dividend of 0.061 per share on Monday, July 6th. This represents a dividend yield of 0.83%. The ex-dividend date is Friday, June 5th. View ALS's dividend history.

Has ALS been receiving favorable news coverage?

News coverage about ALQ stock has been trending somewhat negative recently, according to InfoTrie Sentiment Analysis. The research firm identifies negative and positive news coverage by reviewing more than six thousand blog and news sources. The firm ranks coverage of publicly-traded companies on a scale of negative five to five, with scores closest to five being the most favorable. ALS earned a media sentiment score of -1.0 on InfoTrie's scale. They also assigned news coverage about the company a news buzz of 10.0 out of 10, indicating that recent news coverage is extremely likely to have an effect on the company's share price in the near future. View the latest news about ALS.

Who are some of ALS's key competitors?

What other stocks do shareholders of ALS own?

Based on aggregate information from My MarketBeat watchlists, some companies that other ALS investors own include Honeywell International (HON), Mastercard (MA), Visa (V), Appen (APX), Apollo Education Group (APOL), Antofagasta (ANTO), Arista Networks (ANET), Andeavor (ANDV), Advanced Micro Devices (AMD) and Altium (ALU).

Who are ALS's key executives?

ALS's management team includes the following people:
  • Mr. Raj Naran B.A., B.Sc., MD, CEO & Director (Age 57)
  • Mr. Bruce McDonald, Gen. Mang. of Geochemistry
  • Ms. Kristen Walsh, Gen. Mang. of Industrial
  • Tim Kilmister, Gen. Mang. of Life Sciences APAC
  • Mr. David Prince, Gen. Mang. of Life Sciences Americas

What is ALS's stock symbol?

ALS trades on the ASX under the ticker symbol "ALQ."

What is ALS's stock price today?

One share of ALQ stock can currently be purchased for approximately A$6.37.

How big of a company is ALS?

ALS has a market capitalization of $3.07 billion and generates $1.83 billion in revenue each year.

What is ALS's official website?

The official website for ALS is www.alsglobal.com.

How can I contact ALS?

ALS's mailing address is 299 Coronation Drive PO Box 2191, BRISBANE, QLD 4064, Australia. The company can be reached via phone at +61-7-33677900.

This page was last updated on 7/4/2020 by MarketBeat.com Staff

30 Days of MarketBeat All Access for $1.00

Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools:

  • Best-in-Class Portfolio Monitoring

    View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.

  • Stock Ideas and Recommendations

    Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.

  • Advanced Stock Screeners and Research Tools

    Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.